Endothelial haemostatic markers in members of families with familial combined hyperlipidemia
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F08%3A00006144" target="_blank" >RIV/61989592:15110/08:00006144 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Endothelial haemostatic markers in members of families with familial combined hyperlipidemia
Original language description
Introduction: The aim of this study was to evaluate the plasma levels of endothelial haemostatic markers - von Willebrand factor (sWF), plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (t-PA) and soluble thrombomodulin (sTM) - in asymptomatic, nonsmoking members of families with familial combined hyperlipidemia (FCH). We investigated the association between these factors and the intima-media thickness (IMT) of the common carotid artery, selected risk factors of atherosclerosis andmarkers of insulin resistance. Methods. 82 members of 29 FCH families were divided into two groups: HL (probands and hyperlipidemic first - degree relatives, n=47) and NL (normolipidemic first-degree relatives, n=35). The control groups C-HL (n=20) andC-NL (n=20) consisted of sex- and age-matched healthy individuals. IMT was measured by ultrasound at a far wall of both common carotid arteries. Results: Compared with healthy controls, hyperlipidemic subjects had significantly higher lev
Czech name
Endoteliální hemostatické markery u jedinců z rodin s familiární kombinovanou hyperlipidemií
Czech description
Úvod: Cílem studie bylo stanovit endoteliální hemostatické markery - von Willebrand factor (vWF), plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (t-PA), soluble thrombomodulin (sTM) u asymptomatických jedinců z rodin s familiárníkombinovanou hyperlipidémií (FKH). Zjišťovali jsme vztah těchto markerů k tloušťce intima-media společné karotidy (IMT), k vybraným rizikovým faktorům aterosklerózy a k markerům inzulínové rezistence. Metodika: Do prezentované studie bylo zařazeno 82 osob z 29-ti FKH rodin. Soubor byl rozdělen na hyperlipidemické jedince (HL, n=47) a normolipidemické jedince (NL, n=35). Ke skupině HL, resp. NL byla věkově a pohlavím adjustována kontrolní skupina K-HL (n=20), resp. K-NL (n=20). IMT byla měřena ultrazvukem na vzdálené stěně obou společných karotid. Výsledky: Ve srovnání se zdravými kontrolami, měli hyperlipidemičtí jedinci signifikantně vyšší hladiny vWF (146.4?73.2 % versus 112.2?29.4 %, p<0.05 ), PAI-1 (102.4[83.0-117.0] ng/ml versus 6
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FB - Endocrinology, diabetology, metabolism, nutrition
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/NR9068" target="_blank" >NR9068: Dyslipidemia classification based on concentration of apolipoprotein B and triglycerides. Association of dyslipidemic phenotypes with indices of insulin resistance, inflammation and thrombosis, subclinical and clinical atherosclerosis and DNA markers.</a><br>
Continuities
S - Specificky vyzkum na vysokych skolach
Others
Publication year
2008
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Thrombosis Research
ISSN
0049-3848
e-ISSN
—
Volume of the periodical
123
Issue of the periodical within the volume
3
Country of publishing house
NL - THE KINGDOM OF THE NETHERLANDS
Number of pages
10
Pages from-to
—
UT code for WoS article
—
EID of the result in the Scopus database
—